259 related articles for article (PubMed ID: 37338165)
1. Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats.
Mansooralavi N; Khomula EV; Levine JD
Mol Pain; 2023; 19():17448069231185694. PubMed ID: 37338165
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
[TBL] [Abstract][Full Text] [Related]
3. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
Hirayama Y; Ishitani K; Sato Y; Iyama S; Takada K; Murase K; Kuroda H; Nagamachi Y; Konuma Y; Fujimi A; Sagawa T; Ono K; Horiguchi H; Terui T; Koike K; Kusakabe T; Sato T; Takimoto R; Kobune M; Kato J
Int J Clin Oncol; 2015 Oct; 20(5):866-71. PubMed ID: 25762165
[TBL] [Abstract][Full Text] [Related]
4. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD
Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114
[TBL] [Abstract][Full Text] [Related]
5. Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Okubo Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Hikichi T; Ohira H
Fukushima J Med Sci; 2022 Apr; 68(1):1-10. PubMed ID: 35197393
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
[TBL] [Abstract][Full Text] [Related]
7. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
[TBL] [Abstract][Full Text] [Related]
8. A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy.
Battaglini E; Park SB; Barnes EH; Goldstein D
Contemp Clin Trials; 2018 Jul; 70():135-138. PubMed ID: 29680317
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis.
Chow R; Novosel M; So OW; Bellampalli S; Xiang J; Boldt G; Winquist E; Lock M; Lustberg M; Prsic E
BMJ Support Palliat Care; 2023 Mar; 13(1):27-34. PubMed ID: 36194493
[TBL] [Abstract][Full Text] [Related]
10. Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
Hirayama Y; Yoshida Y; Mori M; Tamura K
Jpn J Clin Oncol; 2020 Aug; 50(8):897-902. PubMed ID: 32424420
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine Attenuates Paclitaxel-Induced Peripheral Nerve Injury by Inhibiting p53-Related Pathways.
Lu Y; Zhang P; Zhang Q; Yang C; Qian Y; Suo J; Tao X; Zhu J
J Pharmacol Exp Ther; 2020 Jun; 373(3):453-462. PubMed ID: 32238452
[TBL] [Abstract][Full Text] [Related]
12. Predictors of the usefulness of duloxetine for chemotherapy-induced peripheral neuropathy.
Kanbayashi Y; Inagaki M; Ueno H; Hosokawa T
Med Oncol; 2017 Aug; 34(8):137. PubMed ID: 28687964
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy.
Kuo A; Corradini L; Nicholson JR; Smith MT
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202809
[TBL] [Abstract][Full Text] [Related]
14. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
Nakamura H; Kawashiri T; Kobayashi D; Uchida M; Egashira N; Shimazoe T
Biol Pharm Bull; 2021; 44(2):271-274. PubMed ID: 33518680
[TBL] [Abstract][Full Text] [Related]
15. Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.
Hu S; Huang KM; Adams EJ; Loprinzi CL; Lustberg MB
Clin Cancer Res; 2019 Nov; 25(21):6295-6301. PubMed ID: 31123053
[TBL] [Abstract][Full Text] [Related]
16. Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice.
Tsubota M; Miyazaki T; Ikeda Y; Hayashi Y; Aokiba Y; Tomita S; Sekiguchi F; Wang D; Nishibori M; Kawabata A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685531
[TBL] [Abstract][Full Text] [Related]
17. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.
Selvy M; Pereira B; Kerckhove N; Busserolles J; Farsi F; Guastella V; Merle P; Pezet D; Balayssac D
Support Care Cancer; 2021 Jul; 29(7):4033-4043. PubMed ID: 33403401
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
Gewandter JS; Kleckner AS; Marshall JH; Brown JS; Curtis LH; Bautista J; Dworkin RH; Kleckner IR; Kolb N; Mohile SG; Mustian KM
Support Care Cancer; 2020 Jun; 28(6):2553-2562. PubMed ID: 31494735
[TBL] [Abstract][Full Text] [Related]
19. Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study.
Giraudet F; Selvy M; Kerckhove N; Pereira B; Barreau F; Nguyen D; Busserolles J; Cabrespine A; Chaleteix C; Soubrier M; Bay JO; Lemal R; Balayssac D
Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):2197-2201. PubMed ID: 35098333
[TBL] [Abstract][Full Text] [Related]
20. Prevention and treatment of chemotherapy-induced peripheral neuropathy.
Piccolo J; Kolesar JM
Am J Health Syst Pharm; 2014 Jan; 71(1):19-25. PubMed ID: 24352178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]